Diabetes mellitus and breast cancer

I Wolf, S Sadetzki, R Catane, A Karasik… - The lancet …, 2005 - thelancet.com
Type 2 diabetes is a serious health problem that affects more than 7% of adults in developed
countries. Up to 16% of patients with breast cancer have diabetes, and two major risk …

Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer

I Wolf, S Levanon-Cohen, S Bose, H Ligumsky… - Oncogene, 2008 - nature.com
Klotho is an anti-aging gene, which has been shown to inhibit the insulin and insulin-like
growth factor 1 (IGF-1) pathways in mice hepatocytes and myocytes. As IGF-1 and insulin …

Cyclophosphamide triggers follicle activation and “burnout”; AS101 prevents follicle loss and preserves fertility

…, M Fishel-Bartal, H Ligumsky, S Paglin, I Wolf… - Science translational …, 2013 - science.org
Premature ovarian failure and infertility are major side effects of chemotherapy treatments in
young cancer patients. A more thorough understanding of the mechanism behind …

Endocrine resistance in breast cancer: focus on the phosphatidylinositol 3-kinase/akt/mammalian target of rapamycin signaling pathway

S Peleg Hasson, T Rubinek, L Ryvo, I Wolf - Breast Care, 2013 - karger.com
Breast cancer is the most common cancer among women. Up to 75% of breast cancers
express the estrogen receptor (ER) α and/or the progesterone receptor (PR). Patients with …

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine among actively treated cancer patients

…, L Galazan, N Arber, I Wolf - JNCI: Journal of the …, 2022 - academic.oup.com
Background Activity and safety of the SARS-CoV-2 BNT162b2 vaccine in actively treated
patients with solid tumors is currently unknown. Methods We conducted a retrospective study of …

Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients

I Wolf, S Sadetzki, H Kanety, Y Kundel, C Pariente… - Cancer, 2006 - Wiley Online Library
BACKGROUND The hormone ghrelin and the adipocytokines leptin and adiponectin
participate in body weight regulation. In response to weight loss, ghrelin and adiponectin levels …

Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor–positive breast cancer

…, G Otto, JS Ross, A Dvir, L Soussan-Gutman, I Wolf… - Clinical cancer …, 2014 - AACR
Purpose: We undertook this study to determine the prevalence of estrogen receptor (ER) α (ESR1)
mutations throughout the natural history of hormone-dependent breast cancer and to …

The role of α-klotho in human cancer: Molecular and clinical aspects

…, K Merenbakh-Lamin, N Keren-Khadmy, I Wolf… - Oncogene, 2022 - nature.com
Klotho is a well-established longevity hormone. Its most prominent function is the regulation
of phosphate homeostasis. However, klotho possesses multiple pleiotropic activities, …

D538G mutation in estrogen receptor-α: A novel mechanism for acquired endocrine resistance in breast cancer

…, VA Miller, D Sarid, S Rizel, B Klein, T Rubinek, I Wolf - Cancer research, 2013 - AACR
Resistance to endocrine therapy occurs in virtually all patients with estrogen receptor α (ERα)-positive
metastatic breast cancer, and is attributed to various mechanisms including loss of …

SIRFLOX: randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective …

…, T Ferguson, J Rodríguez, H Kröning, I Wolf… - Journal of Clinical …, 2016 - ascopubs.org
Purpose SIRFLOX was a randomized, multicenter trial designed to assess the efficacy and
safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …